首页 > 会议日程详情
刘宸佑
苏州大学附属第一医院
2025-11-23
2
论文交流(英文)9 [论文发言]
08:50-08:58
5楼中华C
Atezolizumab-Bevacizumab Versus Sintilimab-Bevacizumab Biosimilar Combined With Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Comparative and Cost-Effectiveness Analysis
查看详情>>
论文交流(英文)10 [论文发言]
09:20-09:28
5楼中华C
Transarterial Chemoembolization Combined with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh B7
查看详情>>